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INTRODUCTION
Indonesia is one of developing countries contributing 
to the increase of population of the world. Based on the 
projection of statistical center Badan Pusat Statistik, 
the number of Indonesian people in the next 20 years 
is going to increase from 238.5 million in 2010 to 
305.6 million in 2035.[1] Total fertility rate in Indonesia 
is also increase, is 2.60 in 2012 from 2.40 the previous 
year.[2] The globally high population will give negative 
impacts that will influence the quality of people’s 
life. Environmental damage, depletion of natural 
resources, lack of water supply, and food availability, 
deterioration of health, and global warming are the 
impact of an increase of the population.
Population growth rate is significantly essential to be 
controlled; therefore, the role of a contraception is highly 
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required. Ideal contraception should be safe, effective, 
practical, and reversible and has minimal side effects. 
The common contraception being used in Indonesia is 
hormonal contraception including combination of pill 
contraception and depot medroxyprogesterone acetate 
(DMPA) injection.[3] Unfortunately, the contraception 
has some weakness relating with the side effects. 
Combination of pill contraception, for example, has 
side effects of nausea, spotting bleeding, amenorrhea,[4] 
dizziness,[5] and the appearance of pimples.[6] Where 
the side effects of contraception of DMPA injection are 
irregular menstruation circle, bleeding, amenorrhea, 
change in body weight, headache, and stomach pain.[7] 
Those side effects surely cause inconvenience to the 
acceptors so that it is important to develop contraception 
method that has minimal side effects.
Alternative contraception method which is intensively 
developed is immunocontraception. The main focus 
of development of immunocontraception research 
by experts is Zona Pellucida (ZP3) because it is 
the primary receptor of introduction of sperm and 
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oocyte.[8] General mechanism of immunocontraception 
with ZP as the major target is distracting or blocking 
carbohydrate and protein receptor on ZP surface 
so that it can cause closure of bonding site between 
sperm and ZP and complete comformational changes 
in the peptide chain resulting in receptors in the egg 
cell cannot be recognized by sperm.[9]
Immunocontraception effectiveness with ZP3 target 
has been tested by various researches both in vitro 
and in vivo. Paterson et al. have proved that antibody 
ZP3 can block the bonding between sperm and human 
ovum until 60%.[10] Bagavant et al. have also proved 
that female bonnet ape (Macaca radiata) that has been 
injected antibody ZP3 becomes infertile along with the 
increase of titer antibody anti-ZP3.[11] The research of 
Lou et al. and Millar et al. has also shown the same 
thing in which the giving of antibody ZP3 can cause 
infertility to mice.[12,13] However, the research dealing 
with immunocontraception has not produced a product 
that is ready to launch to the market. The main cause 
is the controversy of the safety and the side effects 
of using it. Calongos et al. reported that to likely 
preantral of mice cultured with anti-ZP3 can cause 
folliculogenesis disturbance.[14] Different result is stated 
by Bagavant et al. who concludes that female bonnet 
ape (M. radiata) that has gotten antibody ZP3 injection 
does not experience menstruation cicle disturbance. 
Furthermore, from laparoscopy diagnose, it can be seen 
that the ovary is still normal and there is a change of the 
number of follicles on every step of its development.[11]
The development of the immunocontraception method 
has used various kinds of antibody ZP3 of mammals 
both native and recombinant has been frequently 
conducted and has been proved that there is a reaction 
of interspecific antibody to ZP3 on mammals.[15] 
On the other hand, there is still limited data dealing 
with antibody ZP3 of human-caused by the limited 
availability of human oocyte for research.[16] Therefore, 
Mab-hZP3 derived from human blood serum has 
been developed by Mubarakati et al.[17] As potential 
immunocontraception candidate. Moreover, so far 
there has not been any research about the side effect of 
administering Mab-hZP3. Therefore, further research 
to find out the safety of administering Mab-hZP3 on 
folliculogenesis and hormone profile as a contraception 
candidate with various doses and observation time.
Folliculogenesis is closely related to Gap junction 
(GJ). GJ in ovary is mainly composed of connexin 
43 (Cx43), which has important role in the growth 
and development of follicle and oocyte.[18] Interaction 
among cell facilitated by GJ affect hormone 
production and expression of growth factor on 
each follicle compartment (oocyte, granulosa, and 
theca cell).[19] Luteinizing hormone (LH) is one of 
important hormones in providing androgen substrate 
for synthetic estrogen which, in turn, will contribute 
to oocyte maturation and ovulation.
The different results of research about the effects 
of immunocontraception and the limited research 
developing Mab-hZP3 have led to a thought about 
whether the administration of Mab-hZP3 of various 
doses and observation time affects Cx43 expression 
and LH rate of mice (Mus musculus).
MATERIALS AND METHODS
Experimental Animal
Mice that had ever given birth weighing 20–25 g were 
acclimatized and synchronized for 3 weeks. They were 
randomly classified into 12 groups; control group 
(injected with 50 µL adjuvant aluminum hydroxide 
[Al(OH)3] + 50 µL Tris Hcl) and treatment group 
injected with Mab-hZP3 doses 20 µg, 40 µg, and 
60 µg using SC and terminated on the 8th day, 12th day, 
and 16th day on proestrus phase.
Measurement of Expression Cx43
Expression Cx43 was observed from granulosa 
cells of ovarian follicles then procedures of 
immunohistochemistry were performed with primary 
antibody catalog (Bioss, bs-0651R). The assessment 
of expression Cx43 refers to the assessment of 
semiquantitative of Remmele score.
Measurement of LH Levels
Measurement of LH level on blood serum of mice 
(M. musculus) was performed using the method of 
enzyme-linked immunosorbent assay (ELISA) with 
the kit used is mouse LH ELISA kit (ELABSCIENCE, 
USA).
Data Processing
The data processing technique used was an analysis 
of variance (ANOVA) in which first the normality 
and homogeneity were tested. All calculations are 
performed with software of SPSS for Windows 15.0.
RESULTS
Expression Cx43 on Granulosa Cells
Cx43 expression was observed in the cells of 
the ovary secondary granulosa follicles, and 
immunohistochemistry procedures were applied with 
primary antibody catalog (Bioss, bs-0651R) [Figure 1].
The Effect of Mab-hZP3 Various Doses to Cx43 
Expression
Based on the result of the analysis using 
ANOVA, P = 0.125 is greater than α = 0.05, so that 
from this test, it can be concluded that there is no 
significant effect of administering Mab-hZP3 various 
doses to Cx43 expression [Table 1].
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The Effect of Mab-hZP3 Various Times to Cx43 
Expression
Based on the result of analysis using ANOVA, 
P = 0.147 is greater than α = 0.05, so that from this 
test, it can be concluded that there is no significant 
effect of observation time of Cx43 expression on 
administering Mab-hZP3 [Table 2].
The Effect of Mab-hZP3 Various Doses and 
Observation Time to Cx43 Expression
Based on the histogram of the effect of Mab-hZP3 
various doses and observation time to Cx43 expression 
on picture 5.4 above, it shows that the control group 
has the lowest average of Cx43 expression, especially 
on the 12th day. Mab-hZP3 administration of various 
doses increases Cx43 expression in which the highest 
average of Cx43 expression is obtained on a group 
of Mab-hZP3 doses 20 µg (P1) administration with 
16 days of observation; however, it is not a significant 
increase [Figure 2].
Measurement of LH Levels
Measurement of LH level on blood serum of mice 
(M. musculus) was conducted by using ELISA using 
mouse LH Elisa kit (ELABSCIENCE, USA). Based 
on the result of the analysis using ANOVA, P = 0.101 
is greater than α = 0.05, so that from this test, it can be 
concluded that there is no significant effect on giving 
Mab-hZP3 various doses to LH level [Table 3].
The Effect of Observation Time to LH level
Based on the result of analysis using ANOVA, 
P = 0.978 is greater than α = 0.05, so that from this 
test, it can be concluded that there is no significant 
effect of observation time to LH level on administering 
Mab-hZP3 [Table 4].
The Effect of Mab-hZP3 Various Doses and 
Observation Time to LH level
Based on the histogram of the effect Mab-hZP3 
interaction of various doses and observation time to 
LH level on picture 3, it shows that the control group 
has relatively the same average of LH level as all 
groups administering Mab-hZP3 of various doses. The 
administration of Mab-hZP3 of doses 40 µg (P2) and 
60 µg (P3) decrease LH level and the lowest LH level 
is obtained on the group of Mab-hZP3 doses 60 µg 
(P3) administration in 12 days of observation time; 
however statistically, it is not a significant decrease 
[Figure 3].
DISCUSSION
The Effect of Mab-hZP3 Various Doses and 
Observation Time to Cx43 Expression
The result of the research shows that there is no 
significant effect of Mab-hZP3 of various doses and 
observation time to Cx43 expression. The control 
group has the lowest average of Cx43 expression, 
and the administration of Mab-hZP3 various doses 
increases Cx43 expression in which the highest 
average is obtained on the administration group of 
Mab-hZP3 doses 20 µg (P1) in 16 days of observation; 
however, it is not a significant increase statistically.
The result of this research is different from the result 
of research conducted by O’Leary et al. to female 
mice which have been immunized by cytomegalovirus 
mZP3 (mCMV-ZP3) in which there is a significant 
effect on the deterioration of mRNA Cx43 expression 
the condition causes the decrease of granulose cells 
and mature follicles followed by the increase of the 
number of immature follicles.[20] Calongos et al. in his 
research stated that preantral follicles of mice cultured 
with anti-ZP3 antibody, morphologically the ZP is 
thinner compared with the control group.[14] Therefore, 
it can be concluded that the anti-ZP3 antibody is 
suspected to have direct side effect to ZP structure so 
that it can ruin the development of normal GJ between 
oocyte and granulosa cells. Consequently, there is 
two-way communication damage required abnormal 
folliculogenesis. The same result has been obtained by 
Borillo et al. Peptida used to produce ZP3 antibody 
was injected to mice both in vitro and in vivo; it 
Figure 1: Connexin 43 expression is indicated by 
the presence of brown chromogen on granulose cells 
(blue arrow)
Table 1: The effect of Mab-hZP3 various doses to 
C×43 expression
Mab-hZP3 Mean±SD P-value
Control 4.03±2.92 0.125
P1 6.63±2.64
P2 6.32±3.24
P3 5.97±2.05
Table 2: The effect of Mab-hZP3 various times to 
C×43 expression
Time Mean±SD P-value
8 days 4.89±2.78 0.147
12 days 5.48±2.6
16 days 6.85±2.97
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Lloyd et al. concludes that recombinant vaccine ZP3 
given to female mice causes deterioration of transzona 
concentration and follicle damage.[22]
GJis intercellular membrane channel that specifically 
joins a group consisting of 10–10.000 plaques 
on the surface of the membrane[23] formed by the 
interaction of two opposite hemichannel (individual 
connection), in which each connection is formed 
by six protein connection.[24] Therefore, the damage 
and the deterioration of the number of connection 
expressions are Cx43. It is because connection 
expressions are regulated in various levels, including 
by degradation of GJ.[23] Cx43 also known as Gja1 is 
expressed in the compartment of granulose cells. The 
number of Cx43 GJ in each granulose cells increases 
along with the increase of follicle phase, reaching 
maximal number in the final follicular phase. The 
location of subcellular connection 43 in the space 
between oocytes and around cumulus cells indicates 
Figure 2: The effect of Mab-hZP3 various doses and observation time to Cx43 expression
Figure 3: The effect of Mab-hZP3 various doses and observation time to luteinizing hormone level
Table 3: The effect of Mab-hZP3 various doses on 
luteinizing hormone level
Mab-hZP3 Mean±SD P-value
Control 8.71±2.98 0.101
P1 9.51±1.22
P2 7.81±2.02
P3 7.04±2.27
Table 4: The effect of observation time to luteinizing 
hormone level
Time Mean±SD P-value
8 days 8.4±2.12 0.978
12 days 7.47±3.00
16 days 8.93±1.56
shows that the number of GJ formed between oocyte 
and granulosa cells is less than that in the control 
group.[21] The same impact takes place in the process of 
transzona formation which has a role in GJ formation 
between oocytes and granulosa cells. The research of 
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that Cx43 GJ takes part in connecting transzona 
projections.[25]
The result of this research is different from other 
research above in which in this research the 
administration of Mab-hZP3 various doses and 
observation time does not give any effect to Cx43 
expression, in other words, the administration of 
Mab-hZP3 does not give good effect on both the 
number and the damage of GJ so that ZP remains 
normal and undistracted. The basic materials used 
in the research are the same as those in the various 
researches above, which is ZP3. The difference is the 
process of the production in which in this research 
monoclonal hZP3 are used whereas other research 
above use antigen and polyclonal antibodies. Although 
all research could prove the presence of infertility on 
mice immunized with the immunocontraception, the 
impact is significant enough both on folliculogenesis 
disturbance and ovary damage. Therefore, the risk of 
permanent infertility is feared.
A monoclonal antibody is a specific antibody as it has 
only one kind of epitope so that it can only identify 
specific antigen.[26] The high specificity of antibody 
will only react to one target cell. The monoclonal 
antibodies directly go to target cell that is ZP3 and 
affect the function of ZP3 as primary receptor of 
the introduction between spermatozoa and inducer 
of acrosome reaction. Polyclonal antibodies have a 
lot of introductory sites of epitope so that it lacks 
of specificity.[27] The specificity of monoclonal 
antibody has been proved by Bukovsky et al. who 
started that murine monoclonal antibodies (Mabs) 
ZP3 that have been produced show high specificity 
to human ZP3 protein.[28] Moreover, there is no 
cross-reaction of Mabs-ZP3 to the type of ovary 
cells and other tissues, such as endometrium, uterus, 
cervix, fallopian tube, and kidney. Monoclonal 
antibodies hZP3 only recognize ZP3. The advantage 
possessed by Mab ZP3 is better specificity so that 
it is expected to be more effective and safer as 
one of the requirements in developing material of 
immunocontraception.
The stability of Cx43 expression on follicle 
granulose of mice after Mab-hPZ3 injection of 
various doses and observation time matches the 
explanation stated by Barber and Fayrer-Hosken 
about the immunocontraception mechanism after 
the administration of immunocontraception vaccine, 
there is a direct Immunoglobulin G (IgG) secretion 
into the follicles that are related to the formation of 
carbohydrate in the chain of glycans.[9] IgG produced 
is also related to ZP protein on the surface of pellucid 
zone. The bond between sperm and ZP which later can 
cause conformation change so that the sperm cannot 
recognize the receptor and fertility can be prevented.
Another manifestation of immunocontraception 
administration is the early induction of cortical 
reaction that can cause ZP hardening so that ZP 
becomes resistant toward sperm penetration.[9] The 
administration of Mab-hZP3 can increase intracellular 
calcium rate can affect granular exocytosis located 
under plasma membrane which releases enzyme 
working on ZP and harden the ZP. East et al. in 
his research conclude that Mab-mZP3 injection as 
immunocontraception can block fertility by playing 
a role as “specific block” of territory bonding with 
sperm on pellucid zone because ZP3 is the main 
receptor of sperm. Besides, the prevention of sperm 
penetration into ZP caused by oocyte activation and 
early cortical reaction occurs.[29]
Greenhouse et al. reported that the administration 
of Mab-mZP3 of 0.8 mg in 0.5 ml liquid ascites 
can block fertility in 35–80 days after Mab-mZP3 
injection.[30] The same result has also been obtained 
from an experiment conducted by East et al that 
Mab-mZP3 injection at 250 µg can contribute 
contraception effect in 40–80 days after injection. 
However, it is stated that the effectiveness is the same 
as 10 µg of dosage.[29]
The interesting result of this research is that the lowest 
average of Cx43 expression takes place in the control 
group and the administration of Mab-hZP3 all doses 
increase Cx43 expression with the highest Cx43 
expression takes place in the group of Mab-hZP3 
doses 20 µg (P1) administration with observation time 
of 16 days; however, statistically it is not a significant 
increase. The control group in this research was injected 
with adjuvant Al(OH)
3
 in Tris HCl, whereas treatment 
group was injected with Mab-hZP3 in Tris HCl and 
adjuvant Al(OH)
3
. Adjuvant basically has a function 
to assist the effectiveness of antibody administration. 
The function of adjuvant among others is: (1) To store 
immunogen, in this case Mab-hZP3 that can make the 
release runs slower; (2) as a carrier, and as a material 
that can improve vaccine quality.[27]
Various researches have stated that the use of Al(OH)
3 
as adjuvant is safe. Bagavant et al. on his research 
to bonnet ape that was immunized with anti-ZP3 
antibodies concludes that there is no ovary dysfunction 
in using alum as adjuvant.[11] The research of Upadhyay 
et al. which compares ovary morphology between 
the administration of colonization factor antigen and 
Al(OH)
3
 as adjuvant, concludes that there is no ovary 
morphology damage on the ape injected with Al(OH)
3
.[31] 
McKee et al. in his research of Al(OH)
3
 conclude that the 
administration of Al(OH)
3
 can activate natural immune 
respond, macrophage becomes active and produce a lot 
of cytokine proinflammatory.[32] When natural immune 
respond is stimulated leukocyte proinflammatory will 
get into ovary and cause apoptosis of granulose cells;[20] 
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however, the apoptosis can be blocked by extracellular 
matrix that is responsible to maintain the survival of the 
cells.[33]
The low average of Cx43 expression on the whole 
control group compared to the treatment group 
is possibly caused by the administration of alum 
independently so that it can activate natural immune 
response which can reduce Cx43 expression because 
of the role of macrophage and cytokine. However, the 
administration of Al(OH)
3
 on control group does not 
give big impact because statistically it is not significant.
The Effect of the Administration of Mab-hZP3 
Various Doses and Observation Time to LH Level
The result of the test on the effect of Mab-hZP3 various 
doses and observation time to LH level using ANOVA 
is P = 0.618, is greater than α = 0.05; therefore, 
from this test, it can be concluded that there is no 
significant effect of administering Mab-hZP3 various 
doses and observation time to LH level. The research 
is similar to the research conducted by Bagavant 
et al. in which it can be concluded that administration 
of pure anti-ZP3 antibodies to bonnet ape does not 
influence hormonal profile indicated with ovulation 
cycle of the experimental animal.[11] Although 
estradiol concentration of the animal decreases when 
antibody titer reaches its peak, there is no significant 
difference compared with the estradiol rate before it 
was immunized with pure anti-ZP3 antibodies. The 
hormonal profile which was observed every 2 weeks 
did not show any significant change. Each animal 
experienced an ovulatory cycle and infertile, and it 
did not experience menstrual cycle disorders. Besides, 
laparoscopy treatment shows that ovary remains 
normal and follicular development is not disturbed.
The research conducted by Keenan et al. shows the 
same result.[34] The administration of pure porcine ZP3 
antigen to female rabbit does not give any negative 
effect on the endocrine profile in which there is no 
significant effect on LH rate compared with control 
of P = 0.16.
The research of both Bagavant et al. and Keenan 
et al. use the same level of ZP3 immunocontraception 
and hZP3.[11,34] Mubarakati et al. stated that the 
production of hZP3 has undergone a series of process 
which is expected to minimize the side effects.[35] 
Barber and Fayrer-Hosken stated that the side effects 
caused by immunocontraception depend on several 
factors, such as purity, adjuvant, sensitivity of 
experimental animal relating with immunity, and 
the existence of cell T epitope, and cell B of the ZP 
used as immunocontraception material.[9] Female 
dog immunized actively with pZP non purification 
experiences abnormal menstruation cycle, on the other 
hand, pZP immunization that has been purified does 
not cause any effect to menstruation cycle, in other 
words, the menstruation cycle remains normal.[36]
The ovulatory cycle experienced by experimental 
animal in Bagavant et al. research, indicates normal 
rates of LH hormone.[11] Physiologically, in the normal 
cycle of menstruation, follicle-stimulating hormone 
(FSH) induces LH receptor on pre-ovulation of 
granulose cells, allows LH to take over the function 
of FSH in the final phase of follicle maturation. LH 
receptor might also cause granulose cells become 
competent to respond LH increase that finally cause 
ovulation. The ovulation will occur when the threshold 
of LH concentration can be reached, not before the 
time. When the number of LH is too high, it can cause 
early luteinization and atresia follicles might occur 
leading to failure of reaching digraph follicles that can 
prevent ovulation. The low rate of LH level also can 
fail LH increase that can prevent ovulation.[37]
Specificity is very crucial for immunocontraception 
material besides its purification. The specificity 
of monoclonal antibodies has also been proved by 
Widodo and Aulanni’am in their research of the 
administration of rabbit anti-bZP3.[38] After induction 
of bZP3 could recognize ZP3 as its antigene. Sumitro 
et al. also stated that bZP3dG monoclonal antibodies 
have specific characteristics in recognizing bZP3dG 
molecule.[15] It is the specificity that causes Mab-hZP3 
will only react with the target of the ZP3 of mice. It 
has also been proved by the absence of effects Cx43 
GJ compiler of this research.
GJ has a very significant role in the proliferation of 
granulose cells because it has a function of provider 
channel for molecular exchange and transport of 
tiny molecules among granulose cells,[39] including 
intraovarian factors.[37] Follicle development is 
characterized by the increase of the number of granulosa 
cells, starting from one layer in primary follicle phase 
to several layers in antral follicular phase. The lack of 
Cx43 number blocks follicle to develop multiplication 
layers of granulose cells dealing with the deterioration 
of oocyte development. Oocytes are morphologically 
abnormal, meiotically incompetent and could not be 
fertilized.[40] Follicles whose growth is inhibited could 
not reach certain diameter as qualification to become 
dominant follicle; thus, LH surge does not occur so 
that it can cause disturbance of anovulation cycle. 
This research shows that Mab-hZP3 does not affect 
Cx43 expression. It is suspected that one of the causes 
is high specificity so that it could be explained why 
LH levels are also not directly affected.
CONCLUSION
The administration of Mab-hZP3 various doses and 
observation time does not contribute any effect to 
Cx43 expression and LH concentration.
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